Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-02-27 @ 3:13 AM
Study NCT ID:
NCT01244750
Status:
COMPLETED
Last Update Posted:
2022-06-30
First Post:
2010-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12-02
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-15
First Submit QC Date:
None
Study First Post Date:
2010-11-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-28
Last Update Post Date:
2022-06-30
Last Update Post Date Type:
ACTUAL